Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Ipca Laboratories Ltd.
NSE: IPCALAB
|
BSE: 524494
|
ISIN: INE571A01038
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
1505.0000
-22.80
(
-1.49
%)
NSE
Jan 13, 2026
15:29 PM
28.83% Gain from 52W Low
Volume:
147.0K
High vol. this week
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Ipca Laboratories Ltd.
16 Feb 2023
1505.00
-1.49%
Operating deleverage plays a spoil sport
Buy:
Ipca Laboratories Ltd.
by
Motilal Oswal
Target: 990
Target
Motilal Oswal
Number of FII/FPI investors decreased from 270 to 254 in Sep 2025 qtr
More from Ipca Laboratories Ltd.
Recommended
Market trades lower, ICICI Prudential Life Insurance's net profit grows 19% YoY in Q3
Trendlyne Marketwatch |
13 Jan 2026, 03:32PM
IPO wave continues as Amagi Media and Five SMEs open for subscription
|
12 Jan 2026, 06:40PM
IPCA Labs’ domestic formulations business to drive growth
|
05 Jul 2021